Step therapy for Elmiron (pentosan polysulfate sodium)
Defines UnitedHealthcare's step therapy requirement that members must trial amitriptyline before coverage of Elmiron for bladder pain/discomfort associated with interstitial cystitis; applies to pharmacy benefit adjudication.
Program requires a trial of amitriptyline prior to Elmiron coverage.
Annual review. Updated references.
Coverage Criteria
Initial therapy — Covered when ALL of the following are met
Covered when ALL of the following are met
Required prior to approval of Elmiron (pentosan polysulfate sodium).
Coverage criteria may be limited or modified by state mandates, applicable federal regulatory requirements, and the member's specific benefit plan. Other policies and utilization management programs may also affect whether a request meets criteria for coverage.
Provider Actions and Authorization
Prior Authorization Required
Prior authorization is required. Approval is contingent on a documented history of failure, contraindication, or intolerance to amitriptyline; approvals are issued for 12 months. State mandates, federal requirements, and the member's benefit plan may affect coverage.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.